Engineering simulation, or the use of computer models to assess the behavior of a device or treatment in its working environment, is now used by 85 percent of the top 50 healthcare companies as part of their product and process development. Simulating the performance of drugs, devices and therapies in a low-risk, cost-effective virtual environment can develop (disruptive) innovations much faster and at lower cost. Healthcare pioneers have repeatedly reported returns on investment of greater than 500 percent.

Download the whitepaper to discover:

• Threats and opportunities to disruptive trends
• Barriers to capturing disruptive opportunities
• Pervasive simulation through all healthcare sectors

Request Free!